Latest News about ATAI
Recent news which mentions ATAI
2 Top Trends to Invest $2,000 in Ahead of the Crowd
September 05, 2022
From Motley Fool
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 02, 2022
From Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
September 01, 2022
From Benzinga
Psychedelics Funding At Its Best: $1.5 M Destined To Psilocybin Clinical Trials In Australia
September 01, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From August 31, 2022
August 31, 2022
From Benzinga
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
From Benzinga
From Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
August 30, 2022
From InvestorPlace
Small Pharma, Biomind Labs Among Top Psychedelic Movers Of Today
August 29, 2022
From Benzinga
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From August 23, 2022
August 23, 2022
From Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
August 22, 2022
From Benzinga
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From August 17, 2022
August 17, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From August 16, 2022
August 16, 2022
From Benzinga
From Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
August 15, 2022
From Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
From Benzinga
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
August 10, 2022
From Benzinga
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
August 09, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
August 04, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.